Malaria's Spit Solution: A Saliva-based RDT

The Dinglasan laboratory believes malaria elimination is possible, thanks in part to $1.29M from the Global Health Innovative Technology (GHIT) Fund to translate their novel saliva-based RDT into a commercial form: saliva-based malaria asymptomatic and asexual rapid test (SMAART-1). 

Read the story about this innovation here

The GHIT Press Release can be found here!